Literature DB >> 18819056

The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects.

D Papazoglou1, I Panagopoulos, N Papanas, T Gioka, T Papadopoulos, P Papathanasiou, O Kaitozis, K Papatheodorou, E Maltezos.   

Abstract

Fatty amid acid hydrolase (FAAH) has been implicated at both protein and gene level with obesity. An association between Pro129Thr variant of the FAAH gene and obesity has been described, but various studies have yielded conflicting results. Our aim was to determine whether this polymorphism is related to severe obesity and whether it confers a risk for variability of quantitative metabolic traits in a cohort of Greek obese subjects. Two groups of severely obese subjects (BMI > 40 kg/m (2)) were studied: a group of 158 metabolically healthy and a group of 145 obese subjects with metabolic syndrome, which were compared to a control group consisting of 121 lean individuals. We did not find any association between the Pro129Thr polymorphism with severe obesity in both subgroups of obese subjects, between these two subgroups (p= 0.11) or on basic anthropometric characteristics in the three groups. Statistically significant differences were found for glucose and HDL in metabolically healthy subjects and HDL in the control group. The borderline significant p-values were not significant after correction for multiple testing. We were unable to find robust evidence of an association of the Pro129Thr variant with severe obesity, and any related quantitative traits among the obese Greek subjects examined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819056     DOI: 10.1055/s-0028-1087169

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients.

Authors:  D A de Luis; O Izaola; R Aller; B de La Fuente; D Pacheco
Journal:  J Endocrinol Invest       Date:  2013-12       Impact factor: 4.256

2.  385 C/A polymorphism of the fatty acid amide hydrolase gene is associated with metabolic syndrome in the Chinese Han population.

Authors:  Jinyang Zeng; Jianrong Li; Guoliang Huang
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

Review 3.  What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

Authors:  Piotr Schulz; Szymon Hryhorowicz; Anna Maria Rychter; Agnieszka Zawada; Ryszard Słomski; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

4.  Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity.

Authors:  Timo D Müller; Günter Brönner; Melanie Wandolski; Jophia Carrie; Trang T Nguyen; Brandon H Greene; André Scherag; Harald Grallert; Carla Ig Vogel; Susann Scherag; Winfried Rief; Hans-Erich Wichmann; Thomas Illig; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  BMC Med Genet       Date:  2010-01-01       Impact factor: 2.103

5.  Biomarkers of endocannabinoid system activation in severe obesity.

Authors:  Jack C Sipe; T Michael Scott; Sarah Murray; Olivier Harismendy; Gabriel M Simon; Benjamin F Cravatt; Jill Waalen
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

Review 6.  Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review.

Authors:  Justin Matheson; Xin Ming Matthew Zhou; Zoe Bourgault; Bernard Le Foll
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.